Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation
Standard
Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation. / Martin, Claire A; Martin, Ruairidh; Maury, Philippe; Meyer, Christian; Wong, Tom; Dallet, Corentin; Shi, Rui; Gajendragadkar, Parag; Takigawa, Masateru; Frontera, Antonio; Cheniti, Ghassen; Thompson, Nathaniel; Kitamura, Takeshi; Vlachos, Konstantinos; Wolf, Michael; Bourier, Felix; Lam, Anna; Duchâteau, Josselin; Massoullié, Grégoire; Pambrun, Thomas; Denis, Arnaud; Derval, Nicolas; Dubois, Rémi; Hocini, Mélèze; Haïssaguerre, Michel; Jaïs, Pierre; Sacher, Frédéric.
in: CIRC-ARRHYTHMIA ELEC, Jahrgang 12, Nr. 6, 06.2019, S. e007293.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation
AU - Martin, Claire A
AU - Martin, Ruairidh
AU - Maury, Philippe
AU - Meyer, Christian
AU - Wong, Tom
AU - Dallet, Corentin
AU - Shi, Rui
AU - Gajendragadkar, Parag
AU - Takigawa, Masateru
AU - Frontera, Antonio
AU - Cheniti, Ghassen
AU - Thompson, Nathaniel
AU - Kitamura, Takeshi
AU - Vlachos, Konstantinos
AU - Wolf, Michael
AU - Bourier, Felix
AU - Lam, Anna
AU - Duchâteau, Josselin
AU - Massoullié, Grégoire
AU - Pambrun, Thomas
AU - Denis, Arnaud
AU - Derval, Nicolas
AU - Dubois, Rémi
AU - Hocini, Mélèze
AU - Haïssaguerre, Michel
AU - Jaïs, Pierre
AU - Sacher, Frédéric
PY - 2019/6
Y1 - 2019/6
N2 - Background Catheter ablation of ventricular tachycardia (VT) in structural heart disease is challenging because of noninducibility or hemodynamic compromise. Ablation often depends on elimination of local abnormal ventricular activities (LAVAs) but which may be hidden in far-field signal. We investigated whether altering activation wavefront affects activation timing and LAVA characterization and allows a better understanding of isthmus anatomy. Methods Patients with ischemic cardiomyopathy underwent mapping using the ultra-high density Rhythmia system (Boston Scientific). Maps were generated for all stable VTs and with pacing from the atrium, right ventricular apex, and an left ventricular branch of the coronary sinus. Results Fifty-six paced maps and 23 VT circuits were mapped in 22 patients. In 79% of activation maps, there was ≥1 line of block in the paced conduction wavefront, with 93% having fixed block and 32% showing functional partial block. Bipolar scar was larger with atrial than right ventricular (31.7±18.5 versus 27.6±16.3 cm2, P=0.003) or left ventricular pacing (31.7±18.5 versus 27.0±19.2 cm2, P=0.009); LAVA areas were smaller with atrial than right ventricular (12.3±10.5 versus 18.4±11.0 cm2, P<0.001) or left ventricular pacing (12.3±10.5 versus 17.1±10.7 cm2, P<0.001). LAVA areas were larger with wavefront propagation perpendicular versus parallel to the line of block along isthmus boundaries (19.3±7.1 versus 13.6±7.4 cm2, P=0.01). All patients had successful VT isthmus ablation. In 11±8 months follow-up, 2 patients had a recurrence. Conclusions Wavefronts of conduction slowing/block may aid identification of critical isthmuses in unmappable VTs. Altering the activation wavefront leads to significant differences in conduction properties of myocardial tissue, along with scar and LAVA characterization. In patients where few LAVAs are identified during substrate mapping, using an alternate activation wavefront running perpendicular to the VT isthmus may increase sensitivity to detect arrhythmogenic substrate and critical sites for reentry.
AB - Background Catheter ablation of ventricular tachycardia (VT) in structural heart disease is challenging because of noninducibility or hemodynamic compromise. Ablation often depends on elimination of local abnormal ventricular activities (LAVAs) but which may be hidden in far-field signal. We investigated whether altering activation wavefront affects activation timing and LAVA characterization and allows a better understanding of isthmus anatomy. Methods Patients with ischemic cardiomyopathy underwent mapping using the ultra-high density Rhythmia system (Boston Scientific). Maps were generated for all stable VTs and with pacing from the atrium, right ventricular apex, and an left ventricular branch of the coronary sinus. Results Fifty-six paced maps and 23 VT circuits were mapped in 22 patients. In 79% of activation maps, there was ≥1 line of block in the paced conduction wavefront, with 93% having fixed block and 32% showing functional partial block. Bipolar scar was larger with atrial than right ventricular (31.7±18.5 versus 27.6±16.3 cm2, P=0.003) or left ventricular pacing (31.7±18.5 versus 27.0±19.2 cm2, P=0.009); LAVA areas were smaller with atrial than right ventricular (12.3±10.5 versus 18.4±11.0 cm2, P<0.001) or left ventricular pacing (12.3±10.5 versus 17.1±10.7 cm2, P<0.001). LAVA areas were larger with wavefront propagation perpendicular versus parallel to the line of block along isthmus boundaries (19.3±7.1 versus 13.6±7.4 cm2, P=0.01). All patients had successful VT isthmus ablation. In 11±8 months follow-up, 2 patients had a recurrence. Conclusions Wavefronts of conduction slowing/block may aid identification of critical isthmuses in unmappable VTs. Altering the activation wavefront leads to significant differences in conduction properties of myocardial tissue, along with scar and LAVA characterization. In patients where few LAVAs are identified during substrate mapping, using an alternate activation wavefront running perpendicular to the VT isthmus may increase sensitivity to detect arrhythmogenic substrate and critical sites for reentry.
KW - Action Potentials
KW - Aged
KW - Cardiac Pacing, Artificial
KW - Catheter Ablation/adverse effects
KW - Electrophysiologic Techniques, Cardiac
KW - Female
KW - Heart Rate
KW - Heart Ventricles/physiopathology
KW - Humans
KW - Male
KW - Middle Aged
KW - Predictive Value of Tests
KW - Recurrence
KW - Risk Factors
KW - Stroke Volume
KW - Tachycardia, Ventricular/diagnosis
KW - Time Factors
KW - Treatment Outcome
KW - Ventricular Function, Left
U2 - 10.1161/CIRCEP.119.007293
DO - 10.1161/CIRCEP.119.007293
M3 - SCORING: Journal article
C2 - 31122054
VL - 12
SP - e007293
JO - CIRC-ARRHYTHMIA ELEC
JF - CIRC-ARRHYTHMIA ELEC
SN - 1941-3149
IS - 6
ER -